Sirolimus for the treatment of complicated vascular anomalies in children
Pediatric Blood & Cancer2011Vol. 57(6), pp. 1018–1024
Citations Over TimeTop 1% of 2011 papers
Adrienne M. Hammill, MarySue Wentzel, Anita Gupta, Stephen C. Nelson, Anne W. Lucky, Ravi Elluru, Roshni Dasgupta, Richard G. Azizkhan, Denise M. Adams
Abstract
Sirolimus appears to be effective and safe in patients with life-threatening vascular anomalies and represents an important tool in treating these diseases. These findings are currently being further evaluated in a Phase II safety and efficacy trial.
Related Papers
- → Vascular tumors and vascular malformations: Evidence for an association☆, ☆☆(2000)135 cited
- → Vascular anomalies: Presentation and response to medical and surgical management, our experiences in the last 5 years(2019)4 cited
- → Orbital Vascular Anomalies(2019)3 cited
- → Orbital Vascular Anomalies(2020)1 cited
- → Orbital Vascular Anomalies(2011)